Foreseen Biotechnology
We innovate for patients
Taipei, Taiwan · Founded 2021
- Headquarters
- Taipei
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- foreseenbio.com
About
Foreseen Biotechnology is a precision medicine company founded in 2021 by proteomics leader Catherine C.L. Wong and backed by Sequoia China. The company has built a proprietary high-throughput proteomics and multi-omics platform — including SurfSEEN for membrane-protein discovery and PrOmics for AI-assisted target prioritization — to identify novel, clinically translatable disease targets. Its pipeline spans oncology, autoimmune, and neurological diseases, with lead program FS001 (IPN60300), a first-in-class antibody-drug conjugate, licensed to Ipsen in 2024 and currently in Phase I/II clinical trials in the US and Europe.
Summary
Foreseen Biotechnology is a Biotech company based in Taipei, Taiwan, founded in 2021.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/foreseen-biotechnology"><img src="https://indexed.vc/api/badge/company/foreseen-biotechnology" alt="Foreseen Biotechnology on Indexed.vc" width="260" height="76" /></a>